- Home
- OPCH vs IRTC Comparison
OPCH vs IRTC Comparison
Compare OPCH & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPCH
- IRTC
- Stock Information
- Founded
- OPCH N/A
- IRTC 2006
- Country
- OPCH United States
- IRTC United States
- Employees
- OPCH N/A
- IRTC N/A
- Industry
- OPCH Medical/Nursing Services
- IRTC Medical/Dental Instruments
- Sector
- OPCH Health Care
- IRTC Health Care
- Exchange
- OPCH Nasdaq
- IRTC Nasdaq
- Market Cap
- OPCH 5.3B
- IRTC 4.9B
- IPO Year
- OPCH N/A
- IRTC 2016
- Fundamental
- Price
- OPCH $28.70
- IRTC $170.67
- Analyst Decision
- OPCH Strong Buy
- IRTC Strong Buy
- Analyst Count
- OPCH 7
- IRTC 11
- Target Price
- OPCH $36.14
- IRTC $163.82
- AVG Volume (30 Days)
- OPCH 1.7M
- IRTC 531.7K
- Earning Date
- OPCH 07-30-2025
- IRTC 07-31-2025
- Dividend Yield
- OPCH N/A
- IRTC N/A
- EPS Growth
- OPCH 5.29
- IRTC N/A
- EPS
- OPCH 1.26
- IRTC N/A
- Revenue
- OPCH $5,374,021,000.00
- IRTC $657,227,000.00
- Revenue This Year
- OPCH $13.22
- IRTC $25.11
- Revenue Next Year
- OPCH $8.52
- IRTC $16.65
- P/E Ratio
- OPCH $22.81
- IRTC N/A
- Revenue Growth
- OPCH 17.07
- IRTC 22.37
- 52 Week Low
- OPCH $21.39
- IRTC $55.92
- 52 Week High
- OPCH $35.53
- IRTC $172.59
- Technical
- Relative Strength Index (RSI)
- OPCH 45.88
- IRTC 64.96
- Support Level
- OPCH $27.83
- IRTC $165.37
- Resistance Level
- OPCH $28.67
- IRTC $170.84
- Average True Range (ATR)
- OPCH 0.74
- IRTC 4.26
- MACD
- OPCH 0.11
- IRTC 0.25
- Stochastic Oscillator
- OPCH 62.24
- IRTC 85.32
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.